Emerging MS Clinical Options

Has the place for BTK inhibitors in MS been determined? How well do extended interval or alternative B cell depletion dosing regimens work, and for which patients? Do the data support HSCT (hematopoietic stem cell transplant) over high-efficacy DMT — again, for which patients, and with what efficacy and safety? Join us, as guest host Dr. Cole Harrington from the Ohio State University explores these important topics in this issue of eMultipleSclerosis Review. Take our post-test to claim CME credits (https://elit.dkbmed.com/issues/178/test) Read this podcast's companion newsletter here. (https://elit.dkbmed.com/issues/176) Hosted on Acast. See acast.com/privacy for more information.

Episode metadata supplied by the publisher feed · Published Nov 22, 2023

Embed this episode

Attribution link and audio player

Ready to play

Emerging MS Clinical Options

0:00 24:18

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

Gear Tasting Radio Radio ITS Have you ever analyzed why you've chosen the gear you have? Was it based on recommendations, or a true look into the skills to consider when making your selections? Look no further, Gear Tasting Radio is here with an in-depth look into the usage and philosophy behind the equipment in our lives.

Frequently Asked Questions

How long is this episode of DKBmed Radio?

This episode is 24 minutes long.

When was this DKBmed Radio episode published?

This episode was published on November 22, 2023.

Can I download this DKBmed Radio episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!